188 related articles for article (PubMed ID: 37775115)
41. Immunogenic peptide discovery in cancer genomes.
Snyder A; Chan TA
Curr Opin Genet Dev; 2015 Feb; 30():7-16. PubMed ID: 25588790
[TBL] [Abstract][Full Text] [Related]
42. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses.
Axelsson-Robertson R; Weichold F; Sizemore D; Wulf M; Skeiky YA; Sadoff J; Maeurer MJ
Immunology; 2010 Apr; 129(4):496-505. PubMed ID: 20002212
[TBL] [Abstract][Full Text] [Related]
43. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
[TBL] [Abstract][Full Text] [Related]
44. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
45. Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma.
Kawakami Y; Dang N; Wang X; Tupesis J; Robbins PF; Wang RF; Wunderlich JR; Yannelli JR; Rosenberg SA
J Immunother; 2000 Jan; 23(1):17-27. PubMed ID: 10687134
[TBL] [Abstract][Full Text] [Related]
46. SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4
Lacher MD; Bauer G; Fury B; Graeve S; Fledderman EL; Petrie TD; Coleal-Bergum DP; Hackett T; Perotti NH; Kong YY; Kwok WW; Wagner JP; Wiseman CL; Williams WV
Front Immunol; 2018; 9():776. PubMed ID: 29867922
[TBL] [Abstract][Full Text] [Related]
47. Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction.
Abelin JG; Harjanto D; Malloy M; Suri P; Colson T; Goulding SP; Creech AL; Serrano LR; Nasir G; Nasrullah Y; McGann CD; Velez D; Ting YS; Poran A; Rothenberg DA; Chhangawala S; Rubinsteyn A; Hammerbacher J; Gaynor RB; Fritsch EF; Greshock J; Oslund RC; Barthelme D; Addona TA; Arieta CM; Rooney MS
Immunity; 2019 Oct; 51(4):766-779.e17. PubMed ID: 31495665
[TBL] [Abstract][Full Text] [Related]
48. Conformational plasticity of RAS Q61 family of neoepitopes results in distinct features for targeted recognition.
McShan AC; Flores-Solis D; Sun Y; Garfinkle SE; Toor JS; Young MC; Sgourakis NG
Nat Commun; 2023 Dec; 14(1):8204. PubMed ID: 38081856
[TBL] [Abstract][Full Text] [Related]
49. Identification of special AT-rich sequence binding protein 1 as a novel tumor antigen recognized by CD8+ T cells: implication for cancer immunotherapy.
Wang M; Yin B; Matsueda S; Deng L; Li Y; Zhao W; Zou J; Li Q; Loo C; Wang RF; Wang HY
PLoS One; 2013; 8(2):e56730. PubMed ID: 23437226
[TBL] [Abstract][Full Text] [Related]
50. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
51. Presence of strong association of the major histocompatibility complex (MHC) class I allele HLA-A*26:01 with idiopathic hypoparathyroidism.
Goswami R; Singh A; Gupta N; ; Rani R
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1820-4. PubMed ID: 22723329
[TBL] [Abstract][Full Text] [Related]
52.
Schmidt J; Guillaume P; Dojcinovic D; Karbach J; Coukos G; Luescher I
J Biol Chem; 2017 Jul; 292(28):11840-11849. PubMed ID: 28536262
[TBL] [Abstract][Full Text] [Related]
53. Association of HLA-A*11:01, -A*24:02, and -B*18:01 with Prostate Cancer Risk: A Case-Control Study.
Manca MA; Simula ER; Cossu D; Solinas T; Madonia M; Cusano R; Sechi LA
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895076
[TBL] [Abstract][Full Text] [Related]
54. Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
Kissick HT; Sanda MG; Dunn LK; Arredouani MS
PLoS One; 2014; 9(4):e93231. PubMed ID: 24690990
[TBL] [Abstract][Full Text] [Related]
55. Influence of DM-sensitivity on immunogenicity of MHC class II restricted antigens.
Bernhardt AL; Zeun J; Marecek M; Reimann H; Kretschmann S; Bausenwein J; van der Meijden ED; Karg MM; Haug T; Meintker L; Lutzny-Geier G; Mackensen A; Kremer AN
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34266882
[TBL] [Abstract][Full Text] [Related]
56. Phosphosite-dependent presentation of dual phosphorylated peptides by MHC class I molecules.
Zhao Y; Sun M; Zhang N; Liu X; Yue C; Feng L; Ji S; Liu X; Qi J; Wong CCL; Gao GF; Liu WJ
iScience; 2022 Apr; 25(4):104013. PubMed ID: 35310951
[TBL] [Abstract][Full Text] [Related]
57. Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis.
Weichold FF; Mueller S; Kortsik C; Hitzler WE; Wulf MJ; Hone DM; Sadoff JC; Maeurer MJ
Genes Immun; 2007 Jun; 8(4):334-43. PubMed ID: 17429413
[TBL] [Abstract][Full Text] [Related]
58. Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.
Qian J; Xie J; Hong S; Yang J; Zhang L; Han X; Wang M; Zhan F; Shaughnessy JD; Epstein J; Kwak LW; Yi Q
Blood; 2007 Sep; 110(5):1587-94. PubMed ID: 17515399
[TBL] [Abstract][Full Text] [Related]
59. Generation of Phosphopeptide-Specific T Cell Lines as Tools for Melanoma Immunotherapy.
Obeng RC; Ambakhutwala AL
Methods Mol Biol; 2021; 2265():655-670. PubMed ID: 33704746
[TBL] [Abstract][Full Text] [Related]
60. Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens.
Fuchs KJ; Honders MW; van der Meijden ED; Adriaans AE; van der Lee DI; Pont MJ; Monajemi R; Kielbasa SM; 't Hoen PAC; van Bergen CAM; Falkenburg JHF; Griffioen M
Front Immunol; 2020; 11():659. PubMed ID: 32362897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]